COMPANY
Opticyte
NIH awards 6
- NIH award 5R44HL127543-06 FY2022: $910,791 awarded for that fiscal year; activity R44 (SBIR); PI ARAKAKI, LORILEE S. L.; recipient as written: OPTICYTE, INC., Seattle, WA. Noninvasive compact device to monitor myoglo source ↗
- NIH award 5R44HL127543-05 FY2021: $971,485 awarded for that fiscal year; activity R44 (SBIR); PI ARAKAKI, LORILEE S. L.; recipient as written: OPTICYTE, INC., Seattle, WA. Noninvasive compact device to monitor myoglo source ↗
- NIH award 2R44HL127543-04A1 FY2020: $998,586 awarded for that fiscal year; activity R44 (SBIR); PI ARAKAKI, LORILEE S. L.; recipient as written: OPTICYTE, INC., Seattle, WA. Noninvasive compact device to monitor myog source ↗
- NIH award 5R44HL127543-03 FY2017: $500,000 awarded for that fiscal year; activity R44 (SBIR); PI ARAKAKI, LORILEE S. L.; recipient as written: OPTICYTE, INC., Seattle, WA. Real-time myoglobin saturation measurement t source ↗
- NIH award 2R44HL127543-02 FY2016: $500,000 awarded for that fiscal year; activity R44 (SBIR); PI ARAKAKI, LORILEE S. L.; recipient as written: OPTICYTE, INC., Seattle, WA. Real-time myoglobin saturation measurement t source ↗
- NIH award 1R41HL127543-01 FY2015: $150,000 awarded for that fiscal year; activity R41 (STTR); PI ARAKAKI, LORILEE S. L.; recipient as written: OPTICYTE, INC., Seattle, WA. Real-time myoglobin saturation measurement t source ↗